Search Browse Earnings

Trevi Therapeutics, Inc. — SlamSEC

Trevi Therapeutics, Inc.

Nasdaq:TRVI

Pharmaceutical Preparations·NEW HAVEN, CT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$33.8M

FY 2024

Net Income

-$29.1M

FY 2024

EPS (Diluted)

-$0.29

FY 2024

Stock Price

$11.45

-2.6%

2026-03-12

52W Range

$4.85 – $14.39

P/E Ratio

-39.5x

Market Cap

$1.5B

Cash

$32.4M

FY 2024

Total Debt

—

Net Cash

$32.4M

Enterprise Value

$1.4B

Debt / EBITDA

1.0x

FY 2024

EV / EBITDA

-42.5x

Employees

—